Idera Pharmaceuticals acquires biotech firm with pipeline of orphan drugs, takes on new CEO

//Idera Pharmaceuticals acquires biotech firm with pipeline of orphan drugs, takes on new CEO

Idera Pharmaceuticals acquires biotech firm with pipeline of orphan drugs, takes on new CEO

Following the acquisition, the combined company has cash on hand of about $27 million, which provides a runway into the third quarter of 2023.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2022-09-29T03:22:01+00:00 September 29th, 2022|Healthcare|

About the Author: